| Synonyms: | |
| Status: | Approved (2016) |
| Entry Type: | Unknown |
| Molecule Category: | UNKNOWN |
| UNII: | XGF7L72M0F |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| None | Supplement |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Obesity | 3 | D009765 | ClinicalTrials |
| Intestinal Diseases | 3 | D007410 | ClinicalTrials |
| Cardiovascular Diseases | 3 | D002318 | ClinicalTrials |
| Asthma | 3 | D001249 | ClinicalTrials |
| Depressive Disorder | 3 | D003866 | ClinicalTrials |
| Coronary Disease | 3 | D003327 | ClinicalTrials |
| Lipid Metabolism Disorders | 3 | D052439 | ClinicalTrials |
| Cholestasis | 3 | D002779 | ClinicalTrials |
| Arthritis, Rheumatoid | 3 | D001172 | ClinicalTrials |
| Inflammation | 2 | D007249 | ClinicalTrials |
| Epilepsy | 2 | D004827 | ClinicalTrials |
| Liver Diseases | 2 | D008107 | ClinicalTrials |
| Non-alcoholic Fatty Liver Disease | 2 | D065626 | ClinicalTrials |
| Renal Insufficiency, Chronic | 2 | D051436 | ClinicalTrials |
| Brain Concussion | 2 | D001924 | ClinicalTrials |
| Phobia, Social | 2 | D000072861 | ClinicalTrials |
| Fatty Liver | 2 | D005234 | ClinicalTrials |
| Depressive Disorder, Major | 2 | D003865 | ClinicalTrials |
| Neoplasms | 2 | D009369 | ClinicalTrials |
| Multiple Sclerosis | 2 | D009103 | ClinicalTrials |
| Lupus Erythematosus, Systemic | 2 | D008180 | ClinicalTrials |
| Kidney Diseases | 1 | D007674 | ClinicalTrials |
| Diabetic Neuropathies | 1 | D003929 | ClinicalTrials |
| Aging | 1 | D000375 | ClinicalTrials |
| Breast Neoplasms | 1 | D001943 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL3833369 |
| FDA SRS | XGF7L72M0F |
CONTENTS